The gray market, explained

What the gray market is

Most unapproved peptides are sold as "research chemicals — for research use only, not for human consumption." That label is the whole game: it lets a seller ship a substance that is not legal to sell for human use and that has not been reviewed by FDA for safety, effectiveness, or quality.S1S2 A compounded prescription from a licensed pharmacy is a different thing; the gray market is the unlicensed channel that sits outside both approval and compounding.S2

Why some peptides stay here forever

A peptide only completes the approval or bulks-list path if someone pays for it — a new-drug application takes years and millions and needs a sponsor with a reason to fund it. Many peptides have no such sponsor, have thin safety data, or had a nomination quietly withdrawn. Those don't "graduate" — they stay in the gray market indefinitely.S2

What the label may not tell you

Because there's no oversight, "available" is not the reassurance it sounds like. It is not the same as legal for you to use, not the same as proven, and not the same as safe — there's no guarantee of identity, purity, dose, or sterility.S1 Independent testing labs report that roughly a third of gray-market peptide samples fail basic quality checks — mislabeled, wrong dose, or contaminated — including products sold as one peptide that test as another.S3 FDA has separately warned that unapproved semaglutide, tirzepatide, and retatrutide are sold falsely labeled "for research" or "not for human consumption," sometimes carrying the names of pharmacies that never made them.S1

The bottom line

Being for sale is not the same as being proven, legal, or safe — and for a large share of these peptides, it never will be. That's the single fact this whole site is built to make clear.S1S2